Ana Rita Rodrigues on the Impact of Post-Stroke Dysphagia
Ana Rita Rodrigues, Revisor for Health Science Reports at Wiley, shared on LinkedIn:
”Very pleased to see our work on the impact of post-stroke dysphagia highlighted, carried out at the Unidade Local de Saúde de Matosinhos and published in the Revista Portuguesa de Otorrinolaringologia e Cirurgia da Cabeça e Pescoço.
This study — of which I am the first author — analysed 137 patients assessed with fiberoptic endoscopic evaluation of swallowing (FEES) between 2018 and 2023, showing how dysphagia in the acute phase after stroke influences functional prognosis, length of hospital stay, and the risk of respiratory complications.
It is very gratifying to see this highly relevant topic featured by the My Otorrino platform, helping to raise awareness of the importance of early diagnosis and intervention.
A special thank you to the entire multidisciplinary team for their daily commitment to caring for patients with dysphagia.”
Read the full article here.
Article: Clinical and functional impact of oropharyngeal dysphagia after stroke: a retrospective study
Authors: Ana Rita Rodrigues, Adelaide Dias, Delfim Duarte, Nuno Oliveira
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women
-
Jan 25, 2026, 12:32Dino Mehic on Bleeding Assessment Tools and QoL in BDUC
-
Jan 25, 2026, 12:17Natalie Arnold on 11 Clinical Trials That Will Shape Medicine in 2026
-
Jan 25, 2026, 12:05Wolfgang Miesbach on GTH Certification Program for Haemophilia Centres in German-Speaking Countries
-
Jan 25, 2026, 11:46Luma Mahairi on What High-Functioning Teams Can Learn From The Blood System
-
Jan 24, 2026, 15:54Nicolas Nesseler on How Common and Serious is Post-Op Bleeding After Heart Transplantation
-
Jan 24, 2026, 15:43Roey Tagansky on Tu Youyou and the Rediscovery That Defeated Malaria
-
Jan 24, 2026, 15:27Mavis Agnes Kisakye on Community Impact at HFU
-
Jan 24, 2026, 15:15Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration